{"ok":true,"trend":{"id":236687,"platform":"news","region":"global","key":"vyriad begins first-in-human trial of in vivo car t therapy vv169","title":"Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169","url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPYXVOTmNZemI2eGR6R3BnOUo4UHJNdldXd0Q5WmhRZnoxa1VkdC15NHp4US1iZzAyWnVhTTROZTh1VXFwSWFtbUxZbmdPQ3ZQbUlHMjZia0xvb0VQT0NZU0htQV81S0JSX1hSelJlZXNoSTJTQW5ERVpoWENNQmNxNk1JSENKSENOU0hzU3UxSUpobTJkVU5uZXFjZklnUTBfNUZSbUQzbU5EcHM3NHlmOFplSzFFanNBdldXekwzT2VQMEdN?oc=5","first_seen":"2026-09-28T13:16:46.462788Z","last_seen":"2026-09-28T14:41:11.897021Z","last_rank":30,"peak_rank":26,"last_volume":null,"peak_volume":0,"seen_count":2,"score":0.7415625,"category_hint":"medicine","section":"health","category":"medicine","summary":"Biotech company Vyriad has begun the first-in-human clinical trial of VV169, an in vivo CAR T therapy that engineers immune cells inside the patient's body rather than in a lab. The early-stage trial marks a first step in testing the safety of the experimental cancer treatment in people, an approach watched closely as it could simplify a cell therapy process that is currently complex and costly.","why":"First-in-human trials of novel cancer therapies draw attention from investors, clinicians and patients tracking the next generation of cell therapy.","tone":"neutral","entities":["Vyriad","VV169","CAR T therapy"],"summarized_at":"2026-09-28T13:18:25.386221Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"themedicinemaker.com","generic":0.03,"published":"Mon, 28 Sep 2026 12:46:53 GMT"},"nw":0.62,"promo":0.02,"kind":"news_event","importance":1.67,"hidden":false,"hide_reason":null,"judged_at":"2026-09-28T13:16:58.644063Z","title_en":"Vyriad Launches First-in-Human Trial of CAR T Therapy VV169","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-28T13:16:46.462788Z","rank":26,"volume":null},{"captured_at":"2026-09-28T14:41:11.897021Z","rank":30,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPYXVOTmNZemI2eGR6R3BnOUo4UHJNdldXd0Q5WmhRZnoxa1VkdC15NHp4US1iZzAyWnVhTTROZTh1VXFwSWFtbUxZbmdPQ3ZQbUlHMjZia0xvb0VQT0NZU0htQV81S0JSX1hSelJlZXNoSTJTQW5ERVpoWENNQmNxNk1JSENKSENOU0hzU3UxSUpobTJkVU5uZXFjZklnUTBfNUZSbUQzbU5EcHM3NHlmOFplSzFFanNBdldXekwzT2VQMEdN?oc=5","author":"The Medicine Maker","title":"Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169","snippet":null,"posted_at":"2026-09-28T12:46:53Z","likes":null}],"elsewhere":[],"window":"7d"}}